American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
35.30
+0.33 (0.94%)
Jun 6, 2025, 1:29 PM - Market open
American Healthcare REIT Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for American Healthcare REIT stock ranges from a low of $29 to a high of $45. The average analyst price target of $35 forecasts a -0.85% decrease in the stock price over the next year.
Price Target: $35.00 (-0.85%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $37 → $45 | Buy | Maintains | $37 → $45 | +27.48% | May 20, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +4.82% | Apr 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | -3.68% | Mar 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | +4.82% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $34 | Buy | Reiterates | $34 | -3.68% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
2.24B
from 2.06B
Increased by 8.39%
Revenue Next Year
2.38B
from 2.24B
Increased by 6.44%
EPS This Year
0.36
from -0.29
EPS Next Year
0.56
from 0.36
Increased by 53.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.4B | 2.7B | 2.9B |
| Avg | 2.2B | 2.4B | 2.6B |
| Low | 2.1B | 2.2B | 2.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.0% | 19.5% | 23.4% |
| Avg | 8.4% | 6.4% | 8.7% |
| Low | 2.6% | -0.4% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.44 | 0.65 | 0.83 |
| Avg | 0.36 | 0.56 | 0.79 |
| Low | 0.26 | 0.47 | 0.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 79.0% | 48.8% |
| Avg | - | 53.3% | 42.2% |
| Low | - | 29.4% | 37.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.